Key facts
- This page summarizes Birgit Girshick's Form 4 filing for CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL).
- 2 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 23 Feb 2022, 15:23.
Birgit Girshick - 22 Feb 2022 Form 4 Insider Report for CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL)
- Reporting relationship
- Corporate Executive VP & COO
- Issuer ticker
- CRL
- Reported as of
- 22 Feb 2022
- Net transaction value
- -$161,532
- SEC form
- 4
- Accepted by SEC
- 23 Feb 2022, 15:23:52 UTC
- Prior SEC filing
- 01 Feb 2022
- Next SEC filing
- 31 May 2022
- Source filing
- View source filing
- Reporting owner signature
- /s/ Birgit Girshick
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Birgit Girshick filed Form 4 for CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) on 23 Feb 2022.
Change
- Previous filing in this sequence was filed on 01 Feb 2022.
- Current net transaction value: -$161,532.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
CRL
transaction
Common Stock
Tax liability
- Transaction value
- $80,449
- Shares
- -274
- Change %
- -0.8%
- Price
- $293.61
- Shares after
- 33,949
- Date
- 22 Feb 2022
- Ownership
- Direct
CRL
transaction
Common Stock
Tax liability
- Transaction value
- $81,082
- Shares
- -280
- Change %
- -0.82%
- Price
- $289.58
- Shares after
- 33,669
- Date
- 23 Feb 2022
- Ownership
- Direct
* marks a reported price that did not pass the local price check.